Nova Patents
AT497786T

Compositions and kits for enhancing delivery of therapeutic agents to cells

Abstract

The present invention relates to a method of delivering a substance to a cell in which the material is administered to cells in the form of a compound of formula (I) wherein m and n are the same or different and both have an integer from 2 to 8; R is a cationic group or a group having the formula 1; X1 is a compound having the formula 2 or 3; X2 and X3 are independently a saccharide group having 2 or 3 meanings wherein at least one of X2 and X3 is a single saccharide group when R is a compound of structure 1, a delivery enhancing compound. HE

Term

Term ended

Expired 8 July 2018, 8.2 years ago.

  1. Priority
  2. Filed
  3. Granted
  4. Expired
  5. Today

100 members in 25 offices

This recordMember, by publication datePriority claim15 more offices are in the list below

Priority claims1

Priority claims
DocumentOfficeKindDate
88935597United States of AmericaA

Members100

Family members, oldest first
DocumentOfficeKind
CA2242542A1CanadaA1
WO9725072A1World Intellectual Property Organization (WIPO)A1
AU1530097AAustraliaA
US5789244AUnited States of AmericaA
EP0873141A1European Patent Office (EPO)A1
CA2294709A1CanadaA1
WO9902191A1World Intellectual Property Organization (WIPO)A1
ZA986003BSouth AfricaB
AU8390198AAustraliaA
EP1011733A1European Patent Office (EPO)A1
EP0873141A4European Patent Office (EPO)A4
US6165779AUnited States of AmericaA
HU0002683A2HungaryA2
HUP0002683A2HungaryA2
KR20010021620ARepublic of KoreaA
HK1028961AHong Kong, ChinaA
HK1028961A1Hong Kong, ChinaA1
AU732439B2AustraliaB2
IL133929A0IsraelA0
IL133929D0IsraelD0
AR016312A1ArgentinaA1
US2001006946A1United States of AmericaA1
JP2001509492AJapanA
US6312681B1United States of AmericaB1
US6392069B2United States of AmericaB2
TW490306BTaiwan Province of ChinaB
US2002111502A1United States of AmericaA1
NZ502060ANew ZealandA
US2003211598A1United States of AmericaA1
US2004014709A1United States of AmericaA1
AU774338B2AustraliaB2
EP1011733A4European Patent Office (EPO)A4
EP0873141B1European Patent Office (EPO)B1
AT282434TAustriaT
ATE282434T1AustriaT1
AU2004245074A1AustraliaA1
AU2004245995A1AustraliaA1
CA2527658A1CanadaA1
CA2528136A1CanadaA1
WO2004108088A2World Intellectual Property Organization (WIPO)A2
WO2004108898A2World Intellectual Property Organization (WIPO)A2
DE69731611D1GermanyD1
US2005025742A1United States of AmericaA1
US2005085427A1United States of AmericaA1
ES2233995T3SpainT3
HU0002683A3HungaryA3
HUP0002683A3HungaryA3
DE69731611T2GermanyT2
KR20060012661ARepublic of KoreaA
US7002027B1United States of AmericaB1
EP1628624A2European Patent Office (EPO)A2
EP1629085A2European Patent Office (EPO)A2
NO20060019LNorwayL
IL172294A0IsraelA0
IL172294D0IsraelD0
WO2004108088A3World Intellectual Property Organization (WIPO)A3
WO2004108898A3World Intellectual Property Organization (WIPO)A3
BRPI0410915ABrazilA
US2006199782A1United States of AmericaA1
CN1845932AChinaA
CN1852918AChinaA
JP2006526661AJapanA
CO5700786A2ColombiaA2
KR100691572B1Republic of KoreaB1
ZA200600025BSouth AfricaB
JP2007526219AJapanA
JP2007262081AJapanA
JP2007269808AJapanA
US7355056B2United States of AmericaB2
US2008234221A1United States of AmericaA1
NZ543970ANew ZealandA
CN100429220CChinaC
US2009048148A1United States of AmericaA1
CN101396555AChinaA
US7534769B2United States of AmericaB2
US7538093B2United States of AmericaB2
MY138257AMalaysiaA
EP1011733B1European Patent Office (EPO)B1
CA2242542CCanadaC
AT434448TAustriaT
ATE434448T1AustriaT1
DE69840932D1GermanyD1
PT1011733EPortugalE
DK1011733T3DenmarkT3
EP2106807A1European Patent Office (EPO)A1
ES2328094T3SpainT3
US2010028431A1United States of AmericaA1
JP2010070565AJapanA
HK1134025AHong Kong, ChinaA
HK1134025A1Hong Kong, ChinaA1
CA2294709CCanadaC
JP4460148B2JapanB2
EP2106807B1European Patent Office (EPO)B1
AT497786TThis recordAustriaT
ATE497786T1AustriaT1
DE69842133D1GermanyD1
US2011104118A1United States of AmericaA1
ES2362027T3SpainT3
US8022044B2United States of AmericaB2
CY1109367T1CyprusT1